Susan McCune1, Ronald J Portman2. 1. Office of Pediatric Therapeutics, Office of Clinical Policy and Programs, Office of the Commissioner, U.S. Food and Drug Administration. 2. Pediatric Development, Science and Innovation, Pediatric Center of Excellence, Clinical Development & Analytics, Novartis Pharmaceuticals Corporation.
Authors: Margaret Gamalo-Siebers; Lisa Hampson; Kattayoun Kordy; Sebastian Weber; Robert M Nelson; Ronald Portman Journal: Ther Innov Regul Sci Date: 2019-05-13 Impact factor: 1.778